Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News GlaxoSmithKline joins alliance to tackle African diseases

GlaxoSmithKline joins alliance to tackle African diseases

10th September 2014

GlaxoSmithKline has joined a public-private partnership worth five million pounds to study and combat non-communicable diseases in Africa.

Allying with the UK and South African Medical Research Councils, the company will help scientists from South African institutions to conduct research projects into a variety of conditions, thus strengthening the scientific partnership between the two nations.

A total of 2.5 million pounds will be contributed by the UK's Medical Research Council, with 1.5 million pounds coming from its South African counterpart. GlaxoSmithKline will offer the remaining one million pounds, in addition to sharing its internal research expertise.

This aligns with the goals of the company's Africa NCD Open Lab project, which was launched earlier this year to further the firm's work with researchers across Africa.

Patrick Vallance, president of pharmaceutical research and development at GlaxoSmithKline, said the new deal "signifies growing agreement among the scientific community that collaboration is key to defeating some of the world's biggest health problems".

This comes after the company was recently able to work with a number of international partners to fast-track trials of its new Ebola vaccine, which will be used to tackle the current outbreak of the disease in west Africa.ADNFCR-8000103-ID-801747629-ADNFCR

We currently have 10 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.